Clinical Effectiveness of the Queen Square Intensive Comprehensive Aphasia Service for Patients With Poststroke Aphasia.
aphasia
communication
documentation
quality of life
speech
Journal
Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
pubmed:
11
6
2021
medline:
8
1
2022
entrez:
10
6
2021
Statut:
ppublish
Résumé
Poststroke aphasia has a major impact on peoples’ quality of life. Speech and language therapy interventions work, especially in high doses, but these doses are rarely achieved outside of research studies. Intensive Comprehensive Aphasia Programs (ICAPs) are an option to deliver high doses of therapy to people with aphasia over a short period of time. Forty-six people with aphasia in the chronic stage poststroke completed the ICAP over a 3-week period, attending for 15 days and averaging 6 hours of therapy per day. Outcome measures included the Comprehensive Aphasia Test, an impairment-based test of the 4 main domains of language (speaking, writing, auditory comprehension, and reading) which was measured at 3 time points (baseline, immediately posttreatment at 3 weeks and follow-up at 12-week post-ICAP); and, the Communicative Effectiveness Index, a carer-reported measure of functional communication skills collected at baseline and 12 weeks. A 2-way repeated measures multivariate ANOVA was conducted. We found a significant domain-by-time interaction, F=12.7, P<0.0005, indicating that the ICAP improved people with aphasia’s language scores across all 4 domains, with the largest gains in speaking (Cohen’s d=1.3). All gains were maintained or significantly improved further at 12-week post-ICAP. Importantly, patients’ functional communication, as indexed by changes on the Communicative Effectiveness Index, also significantly improved at 12-week post-ICAP, t=5.4, P<0.0005, also with a large effect size (Cohen’s d=0.9). People with aphasia who participated in the Queen Square ICAP made large and clinically meaningful gains on both impairment-based and functional measures of language. Gains were sustained and in some cases improved further over the subsequent 12 weeks.
Sections du résumé
Background and Purpose
Poststroke aphasia has a major impact on peoples’ quality of life. Speech and language therapy interventions work, especially in high doses, but these doses are rarely achieved outside of research studies. Intensive Comprehensive Aphasia Programs (ICAPs) are an option to deliver high doses of therapy to people with aphasia over a short period of time.
Methods
Forty-six people with aphasia in the chronic stage poststroke completed the ICAP over a 3-week period, attending for 15 days and averaging 6 hours of therapy per day. Outcome measures included the Comprehensive Aphasia Test, an impairment-based test of the 4 main domains of language (speaking, writing, auditory comprehension, and reading) which was measured at 3 time points (baseline, immediately posttreatment at 3 weeks and follow-up at 12-week post-ICAP); and, the Communicative Effectiveness Index, a carer-reported measure of functional communication skills collected at baseline and 12 weeks.
Results
A 2-way repeated measures multivariate ANOVA was conducted. We found a significant domain-by-time interaction, F=12.7, P<0.0005, indicating that the ICAP improved people with aphasia’s language scores across all 4 domains, with the largest gains in speaking (Cohen’s d=1.3). All gains were maintained or significantly improved further at 12-week post-ICAP. Importantly, patients’ functional communication, as indexed by changes on the Communicative Effectiveness Index, also significantly improved at 12-week post-ICAP, t=5.4, P<0.0005, also with a large effect size (Cohen’s d=0.9).
Conclusions
People with aphasia who participated in the Queen Square ICAP made large and clinically meaningful gains on both impairment-based and functional measures of language. Gains were sustained and in some cases improved further over the subsequent 12 weeks.
Identifiants
pubmed: 34107735
doi: 10.1161/STROKEAHA.120.033837
pmc: PMC8478085
mid: EMS126116
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e594-e598Subventions
Organisme : Wellcome Trust
ID : 106161
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 106161/Z/14/Z
Pays : United Kingdom
Références
Top Stroke Rehabil. 2013 Sep-Oct;20(5):379-87
pubmed: 24091280
Am J Speech Lang Pathol. 2014 May;23(2):S330-42
pubmed: 24687159
J Speech Hear Disord. 1989 Feb;54(1):113-24
pubmed: 2464719
Cochrane Database Syst Rev. 2016 Jun 01;(6):CD000425
pubmed: 27245310
J Neurol Neurosurg Psychiatry. 2020 Nov 5;:
pubmed: 33154182
Am J Speech Lang Pathol. 2015 Nov;24(4):S854-63
pubmed: 26140692
Disabil Rehabil. 1996 Nov;18(11):567-84
pubmed: 9233854
J Neurol Neurosurg Psychiatry. 2019 May;90(5):498-506
pubmed: 30770457
Top Stroke Rehabil. 2017 Mar;24(2):82-90
pubmed: 27456043
Med Care. 2010 Apr;48(4):380-7
pubmed: 20220536
Stroke. 2003 Apr;34(4):987-93
pubmed: 12649521